“Chinese and Russian vaccines have been disappointing relative to their overall effectiveness”
Vaccines | Opinion | 2 Comment | 06 Feb, 2022
What are your views on the ongoing threat being imposed by the COVID-19 variants across the globe? How can those be best...Read more
CEPI lays focus on developing heat-stable vaccine technology
Vaccines | News | 0 Comment | 04 Feb, 2022
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has launched a new 'Call for Proposals' to...Read more
New Zealand gives provisional nod to first protein-based COVID-19 vaccine
Vaccines | News | 0 Comment | 04 Feb, 2022
US-based Novavax, Inc. has announced that New Zealand's Medsafe has granted provisional approval of NVX-CoV237...Read more
Korean firm EuBiologics receives approval for Ph III trial of COVID-19 vaccine
Vaccines | News | 0 Comment | 04 Feb, 2022
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...Read more
How IP Nitty-gritties Hinder Universal Immunisation?
Vaccines | Analysis | By Ayesha Siddiqui | 1 Comment | 04 Feb, 2022
The coronavirus crisis which has enraged the world has also opened up debates around IP and public health. The gen...Read more
Japan grants patent to Anixa Biosciences for ovarian cancer vaccine
Vaccines | News | 0 Comment | 01 Feb, 2022
US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...Read more
CEPI partners with BioNet to expand variant-proof vaccine programme
Vaccines | News | 0 Comment | 01 Feb, 2022
CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the latest award under its $200 million pr...Read more
Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan
Vaccines | News | 0 Comment | 31 Jan, 2022
Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...Read more
Australia approves Pfizer booster for 16–17 year olds
Vaccines | News | 0 Comment | 28 Jan, 2022
The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...Read more
National Vaccine Institute of Thailand strengthens partnership with International Vaccine Institute
Vaccines | News | 0 Comment | 24 Jan, 2022
The International Vaccine Institute (IVI) in South Korea and the National Vaccine Institute (NVI) of Thailand have signe...Read more
Australia grants provisional registration for Novavax COVID-19 vaccine
Vaccines | News | 0 Comment | 20 Jan, 2022
Novavax, Inc. has announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for p...Read more
How countries are dealing with 'Vaccine Hesitancy'?
Vaccines | Opinion | By Beau Peters, US | 2 Comment | 13 Jan, 2022
The COVID-19 pandemic may well be the worst public health crisis in modern history. But today, the global health system ...Read more
South Korea approves Novavax COVID-19 vaccine
Vaccines | News | 0 Comment | 13 Jan, 2022
US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...Read more
Novavax, Serum Institute of India file for COVID-19 vaccine EUA in South Africa
Vaccines | News | 0 Comment | 11 Jan, 2022
Novavax, Inc. and Serum Institute of India have announced a regulatory submission to the South African Health Products R...Read more
GSK Singapore launches Shingrix vaccine against shingles (herpes zoster)
Vaccines | News | 0 Comment | 10 Jan, 2022
GlaxoSmithKline (GSK) Singapore has launched a new vaccine to help protect against shingles, Shingrix, in...Read more
Pfizer receives EUA of booster shot for 12-15 age group
Vaccines | News | 0 Comment | 04 Jan, 2022
Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency U...Read more
India's COVAXINÒ exhibits safety in paediatric subjects in Ph II/III study
Vaccines | News | 0 Comment | 03 Jan, 2022
Indian firm Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines...Read more
CEPI backs Korea to develop ‘variant-proof’ vaccine candidate
Vaccines | News | 0 Comment | 22 Dec, 2021
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...Read more